Literature DB >> 31938272

Expression level and clinical significance of low-density lipoprotein receptor-related protein 1B gene in cervical squamous cell carcinoma.

Lei Liu1, Mingyong Ren2, Shiyu Han1, Lei Sun1, Li Zhu1.   

Abstract

OBJECTIVE: To quantitatively measure the expression of low-density lipoprotein receptor-related protein 1B gene (LRP1B) in normal and cervical squamous cell carcinoma tissues and explore the correlation between LRP1B gene and age, degree of tumor differentiation, clinical staging, degree of infiltration, lymph node metastasis and the infection of human papilloma virus (HPV) 16/18.
METHODS: Forty patients diagnosed with cervical squamous cell carcinoma and 20 healthy subjects were recruited. The expression of LRP1B mRNA was quantitatively measured by in situ hybridization using LRP1B oligonucleotide probe. The expression of HPV16/18 in the cervical squamous cell carcinoma specimen was investigated.
RESULTS: Among 40 cervical carcinoma samples, the expression level of LRP1B mRNA was down-regulated in 22. Among 20 healthy controls, low expression of LRP1B mRNA was observed in 3. The negative rate of LRP1B mRNA expression in the cervical carcinoma group was significantly lower compared with that in the normal tissues (P<0.05). The positive rate of HPV16/18 in patients with negative LRP1B was significantly higher than that in their counterparts positive for LRP1B (P<0.05). In the cervical carcinoma group, the expression of LRP1B mRNA was not correlated with age, degree of tumor differentiation or clinical staging (all P>0.05). The expression level of LRP1B mRNA in patients with serous membrane infiltration and lymph node metastasis was significantly down-regulated (both P<0.05).
CONCLUSION: LRP1B is lowly expressed in cervical squamous cell carcinoma tissues, suggests LRP1B gene probably acts as a new tumor suppressor gene. LRP1B gene alteration and HPV16/18 infection play a coordinating role in the incidence of cervical cancer. LRP1B expression is intimately correlated with the incidence and metastasis of cervical squamous cell carcinoma. IJCEP
Copyright © 2018.

Entities:  

Keywords:  Cervical squamous cell cancer; HPV16/18; LRP1B; in situ hybridization

Year:  2018        PMID: 31938272      PMCID: PMC6958098     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  10 in total

1.  Genetic or epigenetic silencing of low density lipoprotein receptor-related protein 1B expression in oral squamous cell carcinoma.

Authors:  Takayuki Nakagawa; Atiphan Pimkhaokham; Emina Suzuki; Ken Omura; Johji Inazawa; Issei Imoto
Journal:  Cancer Sci       Date:  2006-10       Impact factor: 6.716

2.  gamma-Secretase-mediated release of the low density lipoprotein receptor-related protein 1B intracellular domain suppresses anchorage-independent growth of neuroglioma cells.

Authors:  Chun-Xiang Liu; Sripriya Ranganathan; Susan Robinson; Dudley K Strickland
Journal:  J Biol Chem       Date:  2007-01-16       Impact factor: 5.157

3.  Striking differences of LDL receptor-related protein 1B expression in mouse and human.

Authors:  Yonghe Li; Wenyan Lu; Guojun Bu
Journal:  Biochem Biophys Res Commun       Date:  2005-08-05       Impact factor: 3.575

4.  Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma.

Authors:  Martine Peter; Nicolas Stransky; Jérôme Couturier; Philippe Hupé; Emmanuel Barillot; Patricia de Cremoux; Paul Cottu; Francois Radvanyi; Xavier Sastre-Garau
Journal:  J Pathol       Date:  2010-07       Impact factor: 7.996

Review 5.  The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review.

Authors:  Domenico Ribatti
Journal:  Br J Haematol       Date:  2005-02       Impact factor: 6.998

6.  Regulation of integrin function by the urokinase receptor.

Authors:  Y Wei; M Lukashev; D I Simon; S C Bodary; S Rosenberg; M V Doyle; H A Chapman
Journal:  Science       Date:  1996-09-13       Impact factor: 47.728

7.  LRP-DIT, a putative endocytic receptor gene, is frequently inactivated in non-small cell lung cancer cell lines.

Authors:  C X Liu; S Musco; N M Lisitsina; E Forgacs; J D Minna; N A Lisitsyn
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

8.  Common fragile sites are preferential targets for HPV16 integrations in cervical tumors.

Authors:  Erik C Thorland; Shannon L Myers; Bobbie S Gostout; David I Smith
Journal:  Oncogene       Date:  2003-02-27       Impact factor: 9.867

9.  Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma.

Authors:  Itaru Sonoda; Issei Imoto; Jun Inoue; Tatsuhiro Shibata; Yutaka Shimada; Koei Chin; Masayuki Imamura; Teruo Amagasa; Joe W Gray; Setsuo Hirohashi; Johji Inazawa
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

10.  Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions.

Authors:  Mihaela Matovina; Ivan Sabol; Goran Grubisić; Nina Milutin Gasperov; Magdalena Grce
Journal:  Gynecol Oncol       Date:  2009-01-21       Impact factor: 5.482

  10 in total
  3 in total

1.  Role of germline variants in the metastasis of breast carcinomas.

Authors:  Ángela Santonja; Aurelio A Moya-García; Nuria Ribelles; Begoña Jiménez-Rodríguez; Bella Pajares; Cristina E Fernández-De Sousa; Elísabeth Pérez-Ruiz; María Del Monte-Millán; Manuel Ruiz-Borrego; Juan de la Haba; Pedro Sánchez-Rovira; Atocha Romero; Anna González-Neira; Ana Lluch; Emilio Alba
Journal:  Oncotarget       Date:  2022-06-30

2.  Effects of LRP1B Regulated by HSF1 on Lipid Metabolism in Hepatocellular Carcinoma.

Authors:  Miaomiao Li; Juntao Hu; Riming Jin; Hongxia Cheng; Huaping Chen; Limin Li; Kun Guo
Journal:  J Hepatocell Carcinoma       Date:  2020-12-08

3.  The Mutation and Expression Level of LRP1B are Associated with Immune Infiltration and Prognosis in Hepatocellular Carcinoma.

Authors:  Mengmeng Wang; Zhifan Xiong
Journal:  Int J Gen Med       Date:  2021-10-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.